Pfizer’s Hair-Loss Oral Treatment Litfulo Gets FDA Approval

News Room

By Sabela Ojea

Pfizer said Friday the Food and Drug Administration has approved Litfulo, its oral treatment for alopecia.

The healthcare company said Litfulo can treat patients aged 12 years and older, becoming the only medication approved by the FDA for adolescents with severe alopecia areata.

Write to Sabela Ojea at [email protected]

Read the full article here

Share this Article
Leave a comment